Does HUMAN C1-ESTERASE INHIBITOR Cause Gait inability? 410 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 410 reports of Gait inability have been filed in association with HUMAN C1-ESTERASE INHIBITOR (Cinryze). This represents 2.9% of all adverse event reports for HUMAN C1-ESTERASE INHIBITOR.
410
Reports of Gait inability with HUMAN C1-ESTERASE INHIBITOR
2.9%
of all HUMAN C1-ESTERASE INHIBITOR reports
399
Deaths
326
Hospitalizations
How Dangerous Is Gait inability From HUMAN C1-ESTERASE INHIBITOR?
Of the 410 reports, 399 (97.3%) resulted in death, 326 (79.5%) required hospitalization, and 325 (79.3%) were considered life-threatening.
Is Gait inability Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for HUMAN C1-ESTERASE INHIBITOR. However, 410 reports have been filed with the FAERS database.
What Other Side Effects Does HUMAN C1-ESTERASE INHIBITOR Cause?
Hereditary angioedema (5,572)
No adverse event (1,660)
Off label use (1,614)
Drug ineffective (1,426)
Intentional product use issue (1,117)
Product use in unapproved indication (1,003)
Weight increased (897)
Maternal exposure during pregnancy (869)
Pain (822)
Condition aggravated (775)
What Other Drugs Cause Gait inability?
ADALIMUMAB (3,844)
ETANERCEPT (2,710)
METHOTREXATE (2,559)
TOFACITINIB (2,227)
SECUKINUMAB (2,216)
TOCILIZUMAB (2,139)
LEFLUNOMIDE (2,065)
RITUXIMAB (2,028)
ABATACEPT (2,019)
HYDROXYCHLOROQUINE (1,881)
Which HUMAN C1-ESTERASE INHIBITOR Alternatives Have Lower Gait inability Risk?
HUMAN C1-ESTERASE INHIBITOR vs HUMAN COAGULATION FACTOR VIII/VON WILLEBRAND FACTOR COMPLEX
HUMAN C1-ESTERASE INHIBITOR vs HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN
HUMAN C1-ESTERASE INHIBITOR vs HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN
HUMAN C1-ESTERASE INHIBITOR vs HUMAN IMMUNOGLOBULIN G
HUMAN C1-ESTERASE INHIBITOR vs HUMAN IMMUNOGLOBULIN G\HYALURONIDASE